<code id='CA6C89F681'></code><style id='CA6C89F681'></style>
    • <acronym id='CA6C89F681'></acronym>
      <center id='CA6C89F681'><center id='CA6C89F681'><tfoot id='CA6C89F681'></tfoot></center><abbr id='CA6C89F681'><dir id='CA6C89F681'><tfoot id='CA6C89F681'></tfoot><noframes id='CA6C89F681'>

    • <optgroup id='CA6C89F681'><strike id='CA6C89F681'><sup id='CA6C89F681'></sup></strike><code id='CA6C89F681'></code></optgroup>
        1. <b id='CA6C89F681'><label id='CA6C89F681'><select id='CA6C89F681'><dt id='CA6C89F681'><span id='CA6C89F681'></span></dt></select></label></b><u id='CA6C89F681'></u>
          <i id='CA6C89F681'><strike id='CA6C89F681'><tt id='CA6C89F681'><pre id='CA6C89F681'></pre></tt></strike></i>

          fashion

          fashion

          author:entertainment    Page View:9
          WuXi AppTec company logo on a phone screen against a backgroud showing stock graph — coverage from STAT
          Adobe

          WASHINGTON — The Biotechnology Innovation Organization, an industry trade group, is cutting ties with Chinese company WuXi in response to increasing U.S. government scrutiny of it and other Chinese companies, according to a BIO press release shared with STAT on Wednesday.

          It’s an about-face for a lobbying organization that recently was willing to defend WuXi against attacks, and it’s a sign that the U.S. biotechnology industry will have to make do without a company that it has come to heavily rely on for developing and making drugs.

          advertisement

          WuXi is the only BIO member among the four Chinese companies that would be blacklisted from doing business in the United States by the Biosecure Act, a bipartisan bill that has been introduced in both the House and Senate.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          AI generated plenty of interest at JPM but not a lot of trust
          AI generated plenty of interest at JPM but not a lot of trust

          AdobeYoudidn’tneedmachinelearningtomakeonepredictionabouttheyear’sbiggestconferenceforhealthcareinve

          read more
          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more

          STAT Readout Newsletter: Today in biotech, life science news

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo